Bull
$118.29
Scenario price
$70.820
-1.905 (-2.69%)At close
Freshpet, Inc. is focused on the development, manufacturing, marketing, and distribution of pet food products. The Company's products consist of dog food, cat food and dog treats. The Company's products are made according to our nutritional philosophy of fresh, nutritional ingredients and minimal processing. Its proprietary recipes include real, fresh meat and varying combinations of vitamin-rich vegetables, leafy greens, and antioxidant-rich fruits, without the use of preservatives or additives. Its products are sold under the Freshpet brand name. The Company sells its products through a network of Company-owned branded refrigerators, Freshpet Fridges. The Company sells its products throughout the United States, Canada, and Europe. It sells its products through various classes of retail: grocery, mass, international, digital, pet specialty, and club. The Company also offers fresh treats across all classes of retail under the Dognation and Dog Joy labels.
Freshpet Inc (FRPT) is currently priced at $70.82, with a forward P/E ratio of 50, indicating high expectations for future earnings growth. The recent Q2 earnings report showed a 15.5% year-over-year increase in net sales, reaching $305.6 million, which exceeded expectations. However, the RSI is at 36.231, suggesting that the stock is approaching oversold territory, and insider selling has increased by 635.99% recently, which could signal caution. Given these mixed signals, it may be prudent to hold rather than buy at this time.
DA Davidson
$95
2026-08-06
DA Davidson
2026-08-06
Price Target
$95
Stifel
$78
2026-08-06
Stifel
2026-08-06
Price Target
$78
Morgan Stanley
$72
2026-08-06
Morgan Stanley
2026-08-06
Price Target
$72
JPMorgan
$72
2026-07-28
JPMorgan
2026-07-28
Price Target
$72
Wells Fargo
$70
2026-07-08
Wells Fargo
2026-07-08
Price Target
$70
Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

Freshpet CEO Sells $6.6 Million in Stock Amid Strategic Trading Plan

Freshpet (FRPT) Q2 2026 Earnings Call Transcript

Freshpet Q2 2026 Earnings Exceed Expectations

Freshpet Q2 Earnings Exceed Expectations with Strong Guidance

Freshpet Reports 15.5% Net Sales Growth in Q2 2026
Freshpet, Inc. is focused on the development, manufacturing, marketing, and distribution of pet food products. The Company's products consist of dog food, cat food and dog treats. The Company's products are made according to our nutritional philosophy of fresh, nutritional ingredients and minimal processing. Its proprietary recipes include real, fresh meat and varying combinations of vitamin-rich vegetables, leafy greens, and antioxidant-rich fruits, without the use of preservatives or additives. Its products are sold under the Freshpet brand name. The Company sells its products through a network of Company-owned branded refrigerators, Freshpet Fridges. The Company sells its products throughout the United States, Canada, and Europe. It sells its products through various classes of retail: grocery, mass, international, digital, pet specialty, and club. The Company also offers fresh treats across all classes of retail under the Dognation and Dog Joy labels. It operates in the Consumer Non-Cyclicals sector (GRAIN MILL PRODUCTS industry).
Freshpet Inc (FRPT) is currently priced at $70.82, with a forward P/E ratio of 50, indicating high expectations for future earnings growth. The recent Q2 earnings report showed a 15.5% year-over-year increase in net sales, reaching $305.6 million, which exceeded expectations. However, the RSI is at 36.231, suggesting that the stock is approaching oversold territory, and insider selling has increased by 635.99% recently, which could signal caution. Given these mixed signals, it may be prudent to hold rather than buy at this time.
10 analysts cover FRPT: 5 rate it Buy, 5 Hold and 0 Sell. The average price target is 71.67.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.